0001564590-21-059041.txt : 20211202 0001564590-21-059041.hdr.sgml : 20211202 20211202081944 ACCESSION NUMBER: 0001564590-21-059041 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20211201 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31938 FILM NUMBER: 211465005 BUSINESS ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 BUSINESS PHONE: 914-347-4300 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 8-K 1 acor-8k_20211201.htm 8-K acor-8k_20211201.htm
false 0001008848 0001008848 2021-12-01 2021-12-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 1, 2021

 

Acorda Therapeutics, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-31938

13-3831168

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

420 Saw Mill River Road,

Ardsley, NY

 

10502

(Address of Principal Executive Offices)

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (914) 347-4300

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

ACOR

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 8.01. Other Events.

 

On December 1, 2021, Acorda Therapeutics, Inc. (the “Company”) issued to the holders of its 6.00% Convertible Senior Secured Notes due 2024 (the “Notes”) an aggregate of 2,049,041 shares of the Company’s common stock (the “Shares”), in satisfaction of approximately $6.2 million in interest due under the Notes on such date. Pursuant to the indenture under which the Notes were issued, the Company may elect to pay interest in cash or shares of the Company’s common stock based on the formula set forth in the indenture. In connection with the issuance of the Shares, an amount corresponding to the $6.2 million of accrued interest will be released from escrow and will be available to the Company for other purposes. The issuance of the Shares was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933.

 

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.

 

Description

4.1

 

Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 26, 2019).

4.2

 

Form of 6.00% Convertible Senior Secured Notes due 2024 (included in Exhibit 4.1)

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Acorda Therapeutics, Inc.

 

 

 

December 2, 2021

By:

/s/ Michael Gesser

 

 

Name: Michael Gesser

 

 

Title: Chief Financial Officer

 

 

 EX-101.SCH 2 acor-20211201.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 acor-20211201_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of each class Security12b Title Trading Symbol Trading Symbol Name of each exchange on which registered Security Exchange Name EX-101.PRE 4 acor-20211201_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 acor-8k_20211201_htm.xml IDEA: XBRL DOCUMENT 0001008848 2021-12-01 2021-12-01 false 0001008848 8-K 2021-12-01 Acorda Therapeutics, Inc. DE 001-31938 13-3831168 420 Saw Mill River Road Ardsley NY 10502 (914) 347-4300 false false false false Common Stock, $0.001 par value per share ACOR NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Dec. 01, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 01, 2021
Entity Registrant Name Acorda Therapeutics, Inc.
Entity Central Index Key 0001008848
Entity Emerging Growth Company false
Entity File Number 001-31938
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 13-3831168
Entity Address, Address Line One 420 Saw Mill River Road
Entity Address, City or Town Ardsley
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10502
City Area Code (914)
Local Phone Number 347-4300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of each class Common Stock, $0.001 par value per share
Trading Symbol ACOR
Name of each exchange on which registered NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports acor-8k_20211201.htm acor-20211201.xsd acor-20211201_lab.xml acor-20211201_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "acor-8k_20211201.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "acor-8k_20211201.htm" ] }, "labelLink": { "local": [ "acor-20211201_lab.xml" ] }, "presentationLink": { "local": [ "acor-20211201_pre.xml" ] }, "schema": { "local": [ "acor-20211201.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "acor", "nsuri": "http://www.acorda.com/20211201", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "acor-8k_20211201.htm", "contextRef": "C_0001008848_20211201_20211201", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "acor-8k_20211201.htm", "contextRef": "C_0001008848_20211201_20211201", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Name of each exchange on which registered" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.acorda.com/20211201/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001564590-21-059041-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-059041-xbrl.zip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end